Myeloid PTEN deficiency impairs tumor-immune surveillance via immune-checkpoint inhibition.
Kuttke M, Sahin E, Pisoni J, Percig S, Vogel A, Kraemmer D, Hanzl L, Brunner JS, Paar H, Soukup K, Halfmann A, Dohnal AM, Steiner CW, Blüml S, Basilio J, Hochreiter B, Salzmann M, Hoesel B, Lametschwandtner G, Eferl R, Schmid JA, Schabbauer G.
Kuttke M, et al. Among authors: salzmann m.
Oncoimmunology. 2016 Mar 28;5(7):e1164918. doi: 10.1080/2162402X.2016.1164918. eCollection 2016 Jul.
Oncoimmunology. 2016.
PMID: 27622019
Free PMC article.